Tibet Weixinkang Medicine Co., Ltd. (603676.SS) SHH

11.15

-0.01(-0.09%)

Updated at January 15 03:00PM

Currency In CNY

Valuation

Market Cap4.3B
Enterprise Value4.09B
P/E Ratio21.71
PEG Ratio-1.35
Price/Sales Ratio4.14
Price/Book Ratio3.16
Enterprise/Revenue3.89
Enterprise/EBITDA16.47

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.19
Operating Margin0.26

Management Effectiveness

Return On Assets0.12
Return On Equity0.15

Income Statement

Revenue1.3B
Revenue/Share2.69
Gross Profit705.3M
EBITDA329.72M
Net Income246.17M
Diluted EPS0.57

Balance Sheet

Total Cash1.02B
Total Cash/Share2.35
Total Debt8.82M
Total Debt/Equity0.01
Current Ratio4.07
Book Value Per Share3.53

Price History

52-Week Change15.07
52-Week High14.94
52-Week Low7.9
Moving Average 50 Days11.09
Moving Average 200 Days11.47

Statistics

Average Volume2.15M
Shares Outstanding432.26M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.33
Trailing Annual Dividend Yield2.93
Payout Ratio0.68
Last Split FactorN/A
Last Split DateN/A